Index of reports
> Cases with Malaise (104)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include malaise. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 104 Next >>
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Product Quality Issue, Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Lisinopril; Seroquel
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise, Renal Impairment, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-20
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-21
End date: 2012-07-12
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-14
Rebetol
Dosage: 200 mg, qod
Administration route: Oral
Start date: 2012-07-13
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-06-08
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-07
Other drugs received by patient: Lendormin; Lansoprazole; Amoban
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-15
End date: 2012-07-13
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Other drugs received by patient: Diflunisal; Januvia; Basen
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-25
Patient:
Reactions: Weight Increased, Dysgeusia, Malaise, Hepatitis C, DRY Mouth
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-09-10
End date: 2012-03-24
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-09-10
End date: 2012-03-30
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-10-19
End date: 2012-03-30
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Administration route: Oral
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Gasmotin; Nizatidine; Motilium
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5 ml, unk
Indication: Hepatitis C
Start date: 2012-04-13
PEG-Intron
Dosage: 0.4 ml, unk
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-13
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Valtrex
Dosage: unk unk, unknown
Indication: Herpes Zoster
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-01
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-09-08
End date: 2012-08-09
Ribavirin
Dosage: unk unk, unknown
Start date: 2011-09-08
End date: 2012-08-09
Other drugs received by patient: Telaprevir
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-07-10
Rebetol
Administration route: Oral
Start date: 2012-05-15
End date: 2012-05-28
Rebetol
Administration route: Oral
Start date: 2012-04-17
Rebetol
Administration route: Oral
Start date: 2012-05-29
Rebetol
Administration route: Oral
Start date: 2012-02-22
End date: 2012-04-16
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-01-30
Rebetol
Administration route: Oral
Start date: 2012-01-31
End date: 2012-02-21
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-01-27
Telavic
Administration route: Oral
Start date: 2012-01-28
End date: 2012-02-13
Telavic
Administration route: Oral
Start date: 2012-02-14
End date: 2012-02-16
Telavic
Administration route: Oral
Start date: 2012-02-17
End date: 2012-04-16
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-21
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-06-17
Rebetol
Administration route: Oral
Start date: 2012-06-18
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-06-24
Telavic
Administration route: Oral
Start date: 2012-06-25
Other drugs received by patient: Voltaren; Mucosta
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Blood Urea Increased, Blood Creatinine Increased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-06-13
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-13
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-13
End date: 2012-07-03
Telavic
Administration route: Oral
Start date: 2012-07-04
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-22
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-02-29
End date: 2012-02-29
PEG-Intron
Dosage: 0mcg/kg
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-14
Rebetol
Administration route: Oral
Start date: 2012-02-15
End date: 2012-03-07
Rebetol
Administration route: Oral
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-28
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-07
Telavic
Administration route: Oral
Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-14
End date: 2012-06-18
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-14
End date: 2012-06-18
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-14
End date: 2012-06-14
Other drugs received by patient: Allegra; Urso 250; Epinastine Hydrochloride
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-14
Patient:
Reactions: Malaise
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-05-15
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-05-14
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-22
End date: 2012-05-24
PEG-Intron
Dosage: 50mcg
Start date: 2012-06-06
PEG-Intron
Dosage: 60 mcg/week
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-05-02
PEG-Intron
Dosage: 50 mcg/week
End date: 2012-05-18
PEG-Intron
Dosage: 40 mcg/week
Start date: 2012-05-11
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-04-25
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-26
End date: 2012-05-07
Rebetol
Administration route: Oral
Start date: 2012-06-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
End date: 2012-05-24
Telavic
Administration route: Oral
Start date: 2012-05-15
End date: 2012-05-21
Telavic
Administration route: Oral
Start date: 2012-05-22
End date: 2012-05-23
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-05-14
Other drugs received by patient: Olmesartan Medoxomil; Olmesartan Medoxomil; Allopurinol
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Malaise, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-29
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Telavic
Administration route: Oral
Start date: 2012-07-04
Telavic
Administration route: Oral
Start date: 2012-05-29
End date: 2012-07-03
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Other drugs received by patient: Olmesartan Medoxomil; Loxonin; Zolpidem; Rebamipide; Amlodipine
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: Malaise, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-08
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
Rebetol
Administration route: Oral
Rebetol
Administration route: Oral
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
Telavic
Administration route: Oral
Start date: 2012-05-08
End date: 2012-07-11
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Stomatitis, Nausea, Pain in Extremity, Pain, Bone Pain, Oral Discomfort, Dysgeusia, Haemoglobin Decreased, Fatigue, Malaise, DRY Mouth, Decreased Appetite, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Rebetol
Dosage: 600 mg, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Victrelis
Dosage: 2400 mg, unknown
Indication: Hepatitis C
Start date: 2012-03-07
Other drugs received by patient: Geodon; Ferrous Sulfate TAB; Ambien; Promethazine; Prozac; Prilosec
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-10
Patient:
Reactions: Off Label Use, Drug Dose Omission, Malaise
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-11-23
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Contusion, Hypersensitivity, Chills, Herpes Zoster, Vascular Injury, Face Oedema, Malaise, Tongue Disorder, Candidiasis, Scratch, Vomiting, Tongue Oedema, Rash, Hypoaesthesia, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Valtrex
Dosage: unk unk, unknown
Indication: Herpes Zoster
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-01
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-02
Patient:
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Dysgeusia, Malaise, Haemolytic Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-22
PEG-Intron
Dosage: 1.5mcg/kg/week
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-04-18
End date: 2012-05-09
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-05-11
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-22
End date: 2012-04-17
Telavic
Administration route: Oral
Start date: 2012-04-18
End date: 2012-05-09
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-22
End date: 2012-04-17
Telavic
Administration route: Oral
Start date: 2012-05-11
End date: 2012-05-22
Other drugs received by patient: Marzulene-S; Nexium; Diovan; Azunol (Sodium Gualenate); Adalat CC; Mucosta
Possible PEG-Intron side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: male
Reactions: Malaise, Injection Site Rash
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: Weight Decreased, Pruritus, Malaise, Nausea, Anaemia, Insomnia, Haemolytic Anaemia, Asthenia, Paraesthesia
Drug(s) suspected as cause:
Investigational Drug (Unspecified)
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-05
End date: 2011-09-29
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-05
End date: 2011-12-01
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-05
End date: 2011-12-01
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-01
Patient:
Reactions: Drug Eruption, White Blood Cell Count Decreased, Depressive Symptom, Pancytopenia, Dysgeusia, Haemoglobin Decreased, Malaise, Diarrhoea, Epistaxis, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100mcg/week
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-24
Rebetol
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-05
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-28
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-05
Other drugs received by patient: Marzulene-S; Mucosta; Urso 250; Famotidine
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-01
Patient:
Reactions: Malaise, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-03
End date: 2012-06-05
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-03
End date: 2012-06-05
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-03
End date: 2012-06-05
Other drugs received by patient: Antebate; Prednisolone; [therapy Unspecified]
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-01
Patient:
Reactions: Product Quality Issue, Malaise, Incorrect Dose Administered
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Japan on 2012-07-31
Patient:
Reactions: Malaise, Nausea, Anaemia, Dizziness, Rash, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-06-03
PEG-Intron
Dosage: 80 ?g, unknown
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
PEG-Intron
Dosage: 80mcg/kg/week
Indication: Hepatitis C
Start date: 2012-06-01
End date: 2012-06-22
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-01
End date: 2012-06-21
Rebetol
Administration route: Oral
Start date: 2012-06-22
End date: 2012-06-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-01
End date: 2012-06-06
Telavic
Administration route: Oral
Start date: 2012-06-07
End date: 2012-06-28
Other drugs received by patient: Levothyroxine Sodium; Levothyroxine Sodium; Lulicon; Equa; Amaryl; Metformin HCL; Aspara CA; Vitamin B12; Pravastatin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-07-31
Patient:
Reactions: Malaise, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-04-15
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-29
Paxil
Dosage: 3 df, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paxil
Administration route: Oral
Indication: Adverse Event
Start date: 2012-02-01
PEG-Intron
Dosage: 80mcg/week
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-01
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-04-16
End date: 2012-04-30
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-02-29
End date: 2012-04-15
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-05-01
PEG-Intron
Dosage: 50mcg/week
Start date: 2012-02-08
End date: 2012-02-15
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Start date: 2012-02-29
End date: 2012-04-15
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Start date: 2012-05-01
Peginterferon Alfa-2B
Dosage: 1.0 ?g/kg, qw
Start date: 2012-04-16
End date: 2012-04-30
Peginterferon Alfa-2B
Dosage: 50 ?g/kg, qw
Start date: 2012-02-08
End date: 2012-02-15
Peginterferon Alfa-2B
Dosage: 80 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-01
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-29
Rebetol
Administration route: Oral
Start date: 2012-02-08
End date: 2012-02-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-09
End date: 2012-04-15
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-07
End date: 2012-05-13
Rebetol
Administration route: Oral
Start date: 2012-02-15
End date: 2012-02-29
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-05-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-12
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-13
End date: 2012-04-08
Rebetol
Administration route: Oral
Start date: 2012-01-17
End date: 2012-02-07
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-04-15
Telavic
Administration route: Oral
Start date: 2012-02-08
End date: 2012-02-14
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-07
Telavic
Administration route: Oral
Start date: 2012-02-15
End date: 2012-02-29
Other drugs received by patient: HI-Z; [composition Unspecified]; Ganaton; Primeperani; Nizatidine; Talion (Bepotastine Besylate); Magmitt; Depas; Primeperani; Ganaton; Zolpidem; Loxonin; Dogmatyl; HI-Z
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-07-31
Patient:
Reactions: Dysgeusia, Malaise, Hypoaesthesia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-05-16
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-05-22
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-05-22
Page 1 Next >>
|